Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibility.
about
Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).Radiologic evaluation of nonalcoholic fatty liver diseaseNoninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.Parametric exploration of the liver by magnetic resonance methodsThe diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisOn the confounding effect of temperature on chemical shift-encoded fat quantification.Comparing average breast fat content results from two different protocols at 1.5T and 3T: can the data be pooled?Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) magnetic resonance imaging as a biomarker for symptomatic multiple myeloma.Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction.Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humansRobust water/fat separation in the presence of large field inhomogeneities using a graph cut algorithm.Chemical shift-based water/fat separation: a comparison of signal models.Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TOn the performance of T2* correction methods for quantification of hepatic fat content.Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Assessment of liver fat quantification in the presence of ironNovel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgeryR*(2) mapping in the presence of macroscopic B₀ field variations.T(2)∗ relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland.Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model.Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?Improved R2* measurement accuracy with absolute SNR truncation and optimal coil combinationAssessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging.MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging.Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy.Magnetic resonance imaging quantification of liver iron.Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosisThe importance of fatty liver disease in clinical practice.Quantification of liver fat with magnetic resonance imaging.Recent advances in imaging hepatic fibrosis and steatosis.Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content.Advanced MR techniques in multicenter clinical trials.Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.The cheating liver: imaging of focal steatosis and fatty sparing.
P2860
Q30303112-8FF515B2-17C4-4F90-8EE6-0BECE163718EQ30436162-F050027E-65A5-4D80-944E-EE08556ABAFCQ30479092-9177E142-A214-47E3-82D2-81A02DE2736EQ30485888-4F79FB5E-F516-492F-BBF9-0D5149E12B94Q30497534-206D8A13-C460-4B17-8978-ECE2FE6D99E6Q30677177-6C026FC2-EC57-4FAC-A65F-9FC6B02B28F6Q30834796-97D61975-8C2C-4E24-938A-E70A8CDA5714Q30897960-E5CBA730-2FFB-4542-96F4-1020FC2F5383Q30989859-2D2A77BE-99F2-4380-8E97-FCEC28E45506Q31155800-7E20081E-3BC2-41FC-AAD9-FCE05BC1F5E0Q33412471-6D001E29-2D0E-4C09-9F26-E55C1DB1D711Q33510900-A7477091-8EFB-4E62-BA39-520D79DA1003Q33512950-531FF1C6-74C5-47EA-A20B-F48898F40522Q33622591-A45186A8-7A30-43A5-85AF-019C4FBE4493Q33787851-B3F0EE10-7D98-4F42-85FF-8849F538513EQ33928955-6522359A-C3DC-40B9-B9C1-B6E8420C5C2EQ33939919-BE5207CD-0AED-4E71-9A8B-971AC3B2AD7FQ34021973-E9A4F939-A8CA-4B5A-B106-3EDF9D7A49B6Q34074615-029093EF-6E63-4D11-956F-02526277B4CBQ34091393-5243A921-7C14-418A-A2F0-074B022F1CE5Q34097331-143C6829-1617-4534-8602-0D9E47312BF0Q34180249-F06F6358-8639-49D6-8804-BA6F7059AB11Q34279653-D6E3A67E-A0C3-4200-BE25-FE3862C8CFC6Q34504586-F564D34B-3A1F-45F6-9B1E-FEDE829EC2F5Q34575945-D4E59803-A720-4DD2-8137-C0D943642BBFQ34596976-22E7485C-5607-4505-BD3A-2153F1632C24Q34819626-E19C0CE9-2463-4F37-B86C-60A9410B13B3Q34990725-351AE082-89EA-4C74-8709-B4DA14C29CC7Q35063507-57FB4562-C54A-4F49-AD86-2902FC98A915Q35212883-B6192298-ED31-44D0-82B5-BEF40B819B92Q36197679-8CF029D3-BCFB-4011-A07F-27AEDC90CECDQ36785616-D848BEC9-49C2-4C31-A0C6-D3FF8806437CQ37766943-767FF55E-9FBE-4415-9414-7557D303D870Q37811338-452C6F1D-3CE4-419D-87D4-2F538292A8B4Q37839093-31FB113B-164B-44F8-9568-80FC8BB2DAA5Q37968566-5E10B3F9-B29E-4F33-87E3-448B6405BF0AQ38092796-0BA4D249-2560-44FD-8240-5074495C9E98Q38446344-1474E821-7407-47F5-B647-3D0AAB3F4DB3Q38625205-440EAE73-66DC-4E61-A2F8-965A5A6B6657Q38793475-5A060C5A-E93D-4764-A17F-6235A1442C68
P2860
Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibility.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@ast
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@en
type
label
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@ast
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@en
prefLabel
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@ast
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@en
P2093
P1433
P1476
Liver fat content and T2*: sim ...... imaging at 3.0 T--feasibility.
@en
P2093
Joseph V Hajnal
Julie Fitzpatrick
Marzena Wylezinska-Arridge
Rossi P Naoumova
Stephan A Schmitz
P304
P356
10.1148/RADIOL.2472070880
P407
P577
2008-03-18T00:00:00Z